We are live on ! Find out more
PL

Perpetual Ltd Portfolio holdings

AUM $7B
1-Year Est. Return 19.75%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+19.75%
3 Year Est. Return
+95.52%
5 Year Est. Return
10 Year Est. Return
AUM
$6.52B
AUM Growth
-$394M
Cap. Flow
-$489M
Cap. Flow %
-7.51%
Top 10 Hldgs %
31.07%
Holding
455
New
44
Increased
191
Reduced
174
Closed
31

Top Buys

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$170M
2
BKR icon
Baker Hughes
BKR
+$114M
3
NWS icon
News Corp Class B
NWS
+$64.7M
4
NU icon
Nu Holdings
NU
+$52.3M
5
GEHC icon
GE HealthCare
GEHC
+$42.6M

Top Sells

Rank Stock Value
1
CDW icon
CDW
CDW
+$148M
2
GXO icon
GXO Logistics
GXO
+$93.9M
3
SPOT icon
Spotify
SPOT
+$89.2M
4
SE icon
Sea Limited
SE
+$70.7M
5
FERG icon
Ferguson
FERG
+$59.4M

Sector Composition

Rank Sector Weight
1 Technology 15.55%
2 Materials 13.2%
3 Industrials 12.2%
4 Utilities 11.62%
5 Financials 11.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXCM icon
326
DexCom
DXCM
$27.6B
$455K 0.01%
7,242
+1,889
+35% +$132K
PEB icon
327
Pebblebrook Hotel Trust
PEB
$2.16B
$455K 0.01%
+35,990
New +$441K
IFF icon
328
International Flavors & Fragrances
IFF
$19.4B
$454K 0.01%
6,264
+63
+1% +$4.62K
BE icon
329
Bloom Energy
BE
$52.6B
$454K 0.01%
3,348
-624
-16% -$91.6K
RKLB icon
330
Rocket Lab Corp
RKLB
$39.9B
$452K 0.01%
+7,032
New +$530K
CTS icon
331
CTS Corp
CTS
$1.72B
$451K 0.01%
9,445
-495
-5% -$24.8K
OKE icon
332
Oneok
OKE
$58.7B
$443K 0.01%
4,898
-1,813
-27% -$149K
NBIX icon
333
Neurocrine Biosciences
NBIX
$17.7B
$443K 0.01%
3,359
+620
+23% +$82.3K
TEAM icon
334
Atlassian
TEAM
$22B
$442K 0.01%
6,482
-11,071
-63% -$1.09M
ENIC icon
335
Enel Chile
ENIC
$5.96B
$441K 0.01%
112,000
-18,000
-14% -$74.9K
SLB icon
336
SLB Ltd
SLB
$77.8B
$438K 0.01%
8,531
HUBS icon
337
HubSpot
HUBS
$10.5B
$437K 0.01%
1,790
-51
-3% -$14.3K
FANG icon
338
Diamondback Energy
FANG
$57.6B
$433K 0.01%
2,190
+300
+16% +$51K
LFUS icon
339
Littelfuse
LFUS
$10.2B
$432K 0.01%
1,273
-88,135
-99% -$28.6M
RPRX icon
340
Royalty Pharma
RPRX
$26.1B
$430K 0.01%
8,960
GH icon
341
Guardant Health
GH
$19.5B
$428K 0.01%
4,638
+301
+7% +$30.2K
AMBQ
342
Ambiq Micro
AMBQ
$1.7B
$423K 0.01%
+16,649
New +$497K
AMRZ
343
Amrize Ltd
AMRZ
$27.3B
$418K 0.01%
7,462
-506
-6% -$29K
ZS icon
344
Zscaler
ZS
$23B
$415K 0.01%
2,956
-95,186
-97% -$16.9M
CHWY icon
345
Chewy
CHWY
$8.54B
$413K 0.01%
15,301
+227
+2% +$6.33K
EW icon
346
Edwards Lifesciences
EW
$47.6B
$412K 0.01%
5,150
+674
+15% +$55.6K
HIG icon
347
Hartford Financial Services
HIG
$38.5B
$409K 0.01%
3,024
+343
+13% +$46.8K
SIBN icon
348
SI-BONE Inc
SIBN
$737M
$402K 0.01%
31,809
+2,064
+7% +$32.3K
VRRM icon
349
Verra Mobility
VRRM
$615M
$399K 0.01%
27,931
+620
+2% +$11.4K
LSCC icon
350
Lattice Semiconductor
LSCC
$17.6B
$397K 0.01%
+4,275
New +$383K

Similar funds

Perpetual Ltd's Q1 2026 Portfolio in Review

As of Q1 2026, Perpetual Ltd held 455 positions worth $6.52B, down 5.7% from $6.91B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Perpetual Ltd withdrew a net $489M in Q1 2026, closing 31 positions and reducing 174 holdings. Its most notable exit was CDW, an estimated $148M position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Materials and Industrials.

Against the trend, Perpetual Ltd opened a new position in TE Connectivity worth $161M.

  • Perpetual Ltd's largest Q1 2026 buy was TE Connectivity: 770,370 shares worth $161M.
  • Perpetual Ltd added most to News Corp Class B in Q1 2026, an estimated $64.7M increase.
  • Perpetual Ltd's biggest Q1 2026 reduction was GXO Logistics, cutting an estimated $93.9M.
  • Perpetual Ltd fully exited CDW in Q1 2026, selling an estimated $148M.
  • Perpetual Ltd's ten largest holdings make up 31% of its $6.52B portfolio in Q1 2026.
  • Perpetual Ltd opened 44 new positions and closed 31 in Q1 2026.
  • Perpetual Ltd's portfolio value fell 5.7% quarter-over-quarter to $6.52B.

Based on Perpetual Ltd's 13F filing for Q1 2026, filed 14 Apr 2026.